| 标题 |
Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Haematology 作者:Abramson JS; Geyer S; Giri S; Pederson L; Hudson A; et al 出版日期:2026/09/01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)